Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yuri Nikolsky
Affiliation
ORCID
Career Start Year
1994
Papers
72
H Index
40
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
28849560
Functional Analysis of OMICs Data and Small Molecule Compounds in an Integrated "Knowledge-Based" Platform.
Methods in Molecular Biology
2017
28849565
Analysis of cis-Regulatory Elements in Gene Co-expression Networks in Cancer.
Methods in Molecular Biology
2017
27774999
Nucleotide diversity analysis highlights functionally important genomic regions.
Scientific Reports
2016
27436340
Toward high-resolution population genomics using archaeological samples.
DNA Res
2016
26747447
The mysterious orphans of Mycoplasmataceae.
Biology Direct
2016
26865217
Genomic study of the Ket: a Paleo-Eskimo-related ethnic group with significant ancient North Eurasian ancestry.
Scientific Reports
2016
27848968
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development.
Nature Communications
2016
27824868
Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer.
PLoS One
2016
27671678
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes.
Cancer Res
2016
26107615
Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib.
PLoS One
2015
26000039
Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors.
Journal of Cancer
2015
26109056
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Genome Biol
2015
25150839
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance.
Nat Biotechnol
2014
24937458
JARID1B is a luminal lineage-driving oncogene in breast cancer.
Cancer Cell
2014
24510058
A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages.
Nat Commun
2014
23593264
Drug target prediction and repositioning using an integrated network-based approach.
PLoS One
2013
23770079
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.
Cell Stem Cell
2013
21861759
A model of early human embryonic stem cell differentiation reveals inter- and intracellular changes on transition to squamous epithelium.
2012
22583392
Prediction of organ toxicity endpoints by QSAR modeling based on precise chemical-histopathology annotations.
2012
22448124
Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.
Sarcoma
2012
22709571
Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.
Journal of Translational Medicine
2012
23176192
Knowledge-based analysis of proteomics data.
BMC Bioinformatics
2012
21098291
Altered antisense-to-sense transcript ratios in breast cancer.
Proc Natl Acad Sci U S A
2012
21838869
A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis.
BMC Systems Biology
2011
21398405
Functional synergies yet distinct modulators affected by genetic alterations in common human cancers.
Cancer Res
2011
21163964
The genetic landscape of the childhood cancer medulloblastoma.
Science
2011
21254873
Quantitative knowledge-based analysis in compound safety assessment.
2011
21533021
Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium.
PLoS Genet
2011
21633165
The JAK2/STAT3 signaling pathway is required for growth of CD44âºCD24â» stem cell-like breast cancer cells in human tumors.
J Clin Invest
2011
20064235
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors.
Breast Cancer Res
2010
20824474
Systems biology approaches to the study of cardiovascular drugs.
Methods in Molecular Biology
2010
21364822
Interactions between an inflammatory response to infection and protein trafficking pathways favor correction of defective protein trafficking in Cystic Fibrosis.
2010
20676074
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
Nat Biotechnol
2010
20676069
Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.
Pharmacogenomics J
2010
20676066
Genomic indicators in the blood predict drug-induced liver injury.
Pharmacogenomics J
2010
20676064
Consistency of predictive signature genes and classifiers generated using different microarray platforms.
Pharmacogenomics J
2010
20377895
Integrated network analysis of transcriptomic and proteomic data in psoriasis.
BMC Systems Biology
2010
20158879
Bimodal gene expression patterns in breast cancer.
BMC Genomics
2010
19597786
Functional analysis of OMICs data and small molecule compounds in an integrated "knowledge-based" platform.
Methods in Molecular Biology
2009
19309513
Identifying disease-specific genes based on their topological significance in protein networks.
BMC Systems Biology
2009
19426536
Network analysis of human glaucomatous optic nerve head astrocytes.
BMC Med Genomics
2009
19776212
Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals.
Toxicol Sci
2009
19760825
Protein networks and pathway analysis. Preface.
Methods in Molecular Biology
2009
19597794
MetaMiner (CF): a disease-oriented bioinformatics analysis environment.
Methods in Molecular Biology
2009
18990241
The transcriptomic signature of fasting murine liver.
BMC Genomics
2008
19014478
A comprehensive functional analysis of tissue specificity of human gene expression.
BMC Biology
2008
19010930
Genome-wide functional synergy between amplified and mutated genes in human breast cancer.
Cancer Res
2008
20020920
Characteristics of genomic signatures derived using univariate methods and mechanistically anchored functional descriptors for predicting drug- and xenobiotic-induced nephrotoxicity.
Toxicology Mechanisms and Methods
2008
18455123
Regulation of in situ to invasive breast carcinoma transition.
Cancer Cell
2008
18772397
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Science
2008
1 - 50 of 72
Column Actions
Search
Recommended Authors
Collaborators
Tatiana Nikolskaya
Co-authored papers
40
Marina Bessarabova
Thomson Reuters Scientific Inc.
Co-authored papers
14
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
12
Weiwei Shi
Co-authored papers
9
Ming Shi
Co-authored papers
8
Weida Tong
National Center for Toxicological Research
Co-authored papers
7
Victor E Velculescu
Co-authored papers
6
Wenjun Bao
SAS Institute Inc Cary
Co-authored papers
6
Russell D Wolfinger
SAS Institute
Co-authored papers
6
Richard J Brennan
Co-authored papers
6
Tieliu Shi
Co-authored papers
5
Tzu-Ming Chu
Co-authored papers
5
Bert Vogelstein
Co-authored papers
5
Rebecca J Leary
Co-authored papers
5
Giovanni Parmigiani
Dana Farber Cancer Institute.
Co-authored papers
5
Donald W Parsons
Texas Children's Hospital
Co-authored papers
5
Xiaole Shirley Liu
Co-authored papers
5
Jun Yao
The University of Texas MD Anderson Cancer Center
Co-authored papers
5
Damir Dosymbekov
Co-authored papers
5
Huixiao Hong
Co-authored papers
5
Kenneth W Kinzler
Co-authored papers
5
Nickolas Papadopoulos
Co-authored papers
5
Andrea L Richardson
Co-authored papers
5
Siân Jones
Co-authored papers
5
Jean Thierry-Mieg
Co-authored papers
4
Pierre R Bushel
Co-authored papers
4
Douglas R Smith
Co-authored papers
4
Charles Wang
Co-authored papers
4
Hong Fang
National Center for Toxicological Research (NCTR)
Co-authored papers
4
Jianying Li
Co-authored papers
4
1 - 30